HomeFile

File

View Category
Mitral valve

MitraClip Procedure Can Be Performed without General Anesthesia

Courtesy of Dr. Carlos Fava. Avoiding general anesthesia in intervention procedures has the benefits of faster recovery and...
solaci -
Learn More
Structural heart disease

The SOURCE 3 Confirms the Good Outcomes of the SAPIEN 3 at One Year Followup

Transcatheter aortic valve replacement (TAVR) was developed as a strategy to treat non-surgical aortic stenosis, and was later...
solaci -
Learn More
Structural heart disease

New Study Confirms TAVR Durability at 5 Years

The ADVANCE study was designed to evaluate the safety and effectiveness of transcatheter aortic valve replacement (TAVR)...
solaci -
Learn More
Coronary disease

2.0-mm DES for Very Small Vessels: Are They Viable?

The reference vessel diameter is a fundamental factor for restenosis after coronary angioplasty even with drug-eluting stents....
solaci -
Learn More
Coronary disease

Effects of Cerebral Radiation on Interventional Cardiologists

In recent years, there has been a growing concern about the occupational hazard for interventional cardiologists who...
solaci -
Learn More
Coronary disease

Excellent Outcomes for the First Sirolimus Eluting Balloon Tested on Instent Restesosis

Much has been done since studies on conventional balloon angioplasty for BMS instent restenosis showed over 40% new revascularization.  Drug...
solaci -
Learn More
Peripheral vascular disease

An Important Study Shows That Renal Function Must Be Cared for in TAVR

Courtesy of Dr. Carlos Fava. The presence of renal dysfunction in the “real world” is over 25% in patients...
solaci -
Learn More
Coronary disease

Bioresorbable Scaffolds Must Not Be Chosen Over Current DES

Although there are 4 approved bioresorbable scaffolds (BRS) in Europe, experts suggest that current drug-eluting stents (DES)...
solaci -
Learn More